Original research
Gastroenterology and Hepatology
Original research relevant to this speciality, newest first.
- Navigation, reminders and automatic referral improve colonoscopy completion after a positive stool test
JAMA Internal Medicine
Systematic review/meta-analysis, 21 studies. Several practical interventions improved follow-up; effects varied across studies. - Eight weeks of sofosbuvir–velpatasvir is noninferior to twelve weeks in selected patients with hepatitis C
The Lancet
RESOLVE randomized trial, 880 treatment-naive, noncirrhotic patients. Per-protocol sustained virological response: 98.8% versus 99.0%. - Robotic esophagectomy increases lymph-node yield without an established survival advantage
JAMA Surgery
Randomized trial, 218 patients. Median node yield: 36 versus 32. Complications were similar; one-year survival did not differ. - Vedolizumab-first treatment was associated with more steroid-free disease stability in ulcerative colitis.
JAMA Network Open
Swedish cohort of 3,263 patients. Hospitalisation rates did not differ significantly from infliximab or adalimumab. Observational comparison. - The SAFE score showed the greatest clinical utility for predicting cirrhosis in steatotic liver disease.
JAMA Internal Medicine